GARY W PACE
CIK 1184778 · last filed 2025-07-31
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$51.72M
Companies
6
Total Filings
81
Lifetime Open-Market Net
-$19.74M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRDF | Director | 2,676,352 | $1.54 | $4.12M | $2.94M | 17 | 2025-07-31 |
| PCRX | Director | 22,127 | $22.99 | $508.7K | -$5.22M | 25 | 2024-03-08 |
| Cardiff Oncology, Inc. (TROV) Delisted | Director | — | — | — | $0 | 1 | 2020-05-01 |
| RMD | Director | 241,736 | $194.78 | $47.09M | -$17.54M | 29 | 2018-05-10 |
| Imunon, Inc. (CLSN) Delisted | Director | 43,356 | $1.96 | $85.0K | $47.5K | 3 | 2010-02-23 |
| Imunon, Inc. (CLN) Delisted | Director | 20,349 | — | — | $37.4K | 4 | 2008-04-29 |
Recent Filings · Page 3 of 9
81 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-03-04 | CRDF | Buy (P) | +1,500 | $13.9K | EDGAR |
| 2020-09-29 | PCRX | Exer (M) | +70,000 | $1.17M | EDGAR |
| 2020-09-17 | CRDF | Buy (P) | +2,550 | $14.5K | EDGAR |
| 2020-06-19 | CRDF | Grant (A) | — | $0 | EDGAR |
| 2020-06-11 | PCRX | Grant (A) | +1,260 | $0 | EDGAR |
| 2020-05-13 | CRDF | Buy (P) | +447,761 | $600.0K | EDGAR |
| 2020-05-01 | Cardiff Oncology, Inc. (TROV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-03-16 | PCRX | Exer (M) | +21,736 | $96.8K | EDGAR |
| 2019-06-06 | PCRX | Grant (A) | +4,134 | $0 | EDGAR |
| 2018-11-21 | PCRX | Buy (P) | +4,500 | $207.8K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.